Abstract
The results of an investigation on plasma levels of gastrointestinal hormones in patients after the construction of a pelvic reservoir are reported. Enteroglucagon (EG) and peptide tyrosine-tyrosine (PYY), two hormones believed to play a relevant role in the adaptive response of bowel resection, were investigated using a specific radioimmunoassay in basal conditions and after a standard meal. Pouch patients showed a statistically significant increase in basal levels of both enteroglucagon and PYY compared with control subjects ( P <0.02 and P <0.001, respectively). The response of enteroglucagon to food ingestion, evaluated by means of the total integrated response, was similar in patients and controls. Conversely, the response of PYY was significantly increased in pouch patients compared with control cases ( P <0.02). Results of this investigation suggest that gut hormones may be involved in mediating the adaptive response of the intestine to pouch construction. Changes of gut peptides may explain, at least in part, the functional results observed after pouch construction.
Similar content being viewed by others
References
Parks AG, Nicholls RJ. Proctocolectomy without ileostomy for ulcerative colitis. Br Med J 1978;2:85–8.
Fonkalsrud EW. Update on clinical experience with different surgical techniques of the endorectal pull-through operation for colitis and polyposis. Surg Gynecol Obstet 1987;165:309–16.
Nicholls RJ. Restorative proctocolectomy with various types of reservoir World J Surg 1987;11:751–62.
Phillip SSF. Biological effects of a reservoir at the end of the small bowel. World J Surg 1987;11:763–8.
Sagor GR, Ghatei MA, Al-Mukhtar MYT, Wright NA, Bloom SR. Evidence for a humoral mechanism after small intestinal resection: exclusion of gastrin but not enteroglucagon. Gastroenterology 1983;84:902–6.
Besterman HS, Adrian TE, Mallinson CN, et al. Gut hormone release after intestinal resection. Gut 1982;23:854–61.
Adrian TE, Ferri GL, Bacarese-Hamilton AJ, Fuessl HS, Polak JM, Bloom SR. Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 1985;89:1070–7.
Adrian TE, Savage AP, Bacarese-Hamilton AJ, Wolfe K, Besterman HS, Bloom SR. Peptide YY abnormalities in gastrointestinal diseases. Gastroenterology 1986;90:379–84.
Adrian TE, Savage AP, Sagor GR, et al. Effect of peptide YY on gastric pancreatic and biliary function in humans. Gastroenterology 1985;89:494–9.
Savage AP, Adrian TE, Carolan G, Chatterjee VK, Bloom SR. Effects of PYY on mouth to caecum intestinal transit time. Gut 1987;28:166–70.
Guo YS, Singh P, Gomez G, Greeley GH Jr, Thompson JC. Effect of peptide YY on cephalic, gastric and intestinal phases of gastric acid secretion and the release of gastrointestinal hormones. Gastroenterology 1987;92:1202–8.
Soria A, Beubler E. Neuropeptide Y (NPY) and Peptide YY (PYY) inhibit prostaglandin E2 induced intestinal fluid and electrolyte secretion in the rat jejunum in vivo. Eur J Pharmacol 1985;1119:47–52.
Friel DD, Miller RJ, Walker MW. Neuropeptide Y: a powerful modulator of epithelial ion transport. Br J Pharmacol 1986;88:425–31.
Laburthe M, Cheanut B, Rouyer-Fessard C. Interaction of peptide YY with rat intestinal epithelial plasma membranes: binding of the radioiodinated peptide. Endocrinology 1986;118:1910–17.
Bottcher G, Sjolund K, Ekblad E, Hakanson R, Schwarz TW, Sundler F. Coexistence of peptide YY and glicentin immunoreactivity in endocrine cells of the gut. Regul Pept 1984;8:261–6.
Bottler G, Alumets J, Hakanson R, Sundler F. Coexistence of glicentin and peptide YY in colorectal L cells in cat and man: an electron microscopic study. Regul Pept 1986;13:283–91.
Ghatei MA, Bloom SR. Enteroglucagon in man. In: Bloom SR, Polak JM, eds. Gut hormones. vol. Edinburgh: Churchill Livingstone. 1981;2:332–8.
Pemberton JH, Kelly KA, Beart RW, Dozois RR, Wolff BG, Ilstrup DM. Ileal pouch-anal anastomosis for chronic ulcerative colitis. Ann Surg 1987;206:504–13.
Pescatori M, Mattana C, Castagneto M. Clinical and functional results after restorative proctocolectomy. Br J Surg 1988;75:321–4.
Besterman HS, Mallinson CN, Modigliani R, et al. Gut hormones in inflammatory bowel disease. Scand J Gastroenterol 1983;18:845–52.
Adrian TE, Savage AP, Fuessl HS, Wolfe K, Besterman HS, Bloom SR. Release of peptide YY (PYY) after resection of small bowel, colon or pancreas in man. Surgery 1987;101:715–19.
Savage AP, Gornacz GE, Adrian TE, et al. Is raised plasma peptide YY after intestinal resection in the rat responsible for the trophic response? Gut 1985;26:2353–8.
Marley JE, Levine AS, Grace M, Knee J. Peptide (YY), a potent orexigenic agent. Brain Res 1985;341:200–3.
Stanley BG, Daniel DR, Chin AS, Leibowitz SF. Paraventricular nucleus injections of peptide YY and neuropeptide Y preferentially enhance carbohydrate ingestion. Peptides 1985:6:1205–11.
Pietroletti R, Slors FJM, Carlei F, Taat CW, Simi M, Brummelkamp WH. Immunocytochemical study of endocrine cells in pelvic ileal reservoirs. Dis Colon Rectum 1990 (in press).
References
Heppell J, Taylor BM, Beart RW, Dozois RR, Kelly K. Predicting outcome after endorectal ileoanal anastomosis. Can J Surg 1983;26:132–4.
O'Connell PR, Pemberton JH, Brown ML, Kelly KA. Determinants of stool frequency after ileal pouch-anal anastomosis. Am J Surg 1987;153:157–64.
Pappas TN, Chang AM, Bebas HT, Taylor IL. Does peptide YY (PYY) mediate the ileal brake? Gastroenterology 1985;88:1529.
Spiller RC, Trotman IF, Higgins BE, et al. The ileal brake—inhibition of jejunal motility after ileal fat perfusion in man. Gut 1984;25:365–74.
Adrian TE, Savage AP, Sagor GR, et al. Effect of peptide YY on gastric, pancreatic, and biliary function in humans. Gastroenterology 1985;89:494–9.
Saria A, Beubler E. Neuropeptide Y (NPY) and peptide YY (PYY) inhibit prostaglandin E2-induced intestinal fluid and electrolyte secretion in rat jejunum in the rat jejunum in vivo. Eur J Pharmacol 1985;119:47–52.
Savage AP, Adrian TE, Carolan G, Chatterjee VK, Bloom SR. Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. Gut 1987;28:166–70.
Audousset-Puech MP, Jarrousse C, Dubrasquet M, Aumelas A, Castro B, Bataille MJ. Synthesis of the C-terminal octapeptide of pig oxyntomodulin. Lys-Arg-Asn-Lys-Asn-Asn-Ile-Ala: a potent inhibitor of pentagastrin-induced acid secretion. J Med Chem 1985;28:1529–33.
Kock NG, Darle N, Dotevall. Inhibition of intestinal motility in man by glucagon given intraportally. Gastroenterology 1967;53:88–92.
Sagor JR, Gathei MA, Al-Mukhtar MYT, Wright NA, Bloom SR. Evidence for a humoral mechanism after small intestinal resection: Exclusion of gastrin but not enteroglucagon. Gastroenterology 1983;84:902–6.
Soper NJ, Chapman NJ, Kelly KA, Brown ML, Phillips SF, Go VL. The ‘ileal brake’ after ileal pouch-anal anastomosis. Gastroenterology 1990;98:111–6.
Ballantyne GH, Longo WE, Adrian TE, Vukasin A, Bilchik Modlin IM. Deoxycholate-stimulated release of peptide YY from the isolated perfused rabbit left colon. Am J Physiol 1989;257 (Gastrointest Liver Physiol 20): G715–G724.
Author information
Authors and Affiliations
About this article
Cite this article
Pietroletti, R., Slors, F.J.M., Mariani, P. et al. Enteroglucagon and peptide Y-Y response after construction of a pelvic reservoir in humans. Dis Colon Rectum 33, 966–970 (1990). https://doi.org/10.1007/BF02139107
Issue Date:
DOI: https://doi.org/10.1007/BF02139107